Clinical Trial Update: Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update of a pneumococcal vaccine booster in healthy children 11-18 months previously primed with the same vaccines; study completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acellular Pertussis
• Diphtheria
• Hepatitis B
• Poliomyelitis
• Streptococcus Pneumoniae Vaccines
• Tetanus

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Acellular Pertussis | Phase 3 | Status: COMPLETED | Results posted: 2009-08-03